pubmed.ncbi.nlm.nih.gov

Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline - PubMed

Comparative Study

Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline

Britta Haenisch et al. Fundam Clin Pharmacol. 2010 Dec.

Abstract

Oxymetazoline and xylometazoline are both used as nasal mucosa decongesting α-adrenoceptor agonists during a common cold. However, it is largely unknown which of the six α-adrenoceptor subtypes are actually present in human nasal mucosa, which are activated by the two alpha-adrenoceptor agonists and to what extent. Therefore, mRNA expression in human nasal mucosa of the six α-adrenoceptor subtypes was studied. Furthermore, the affinity and potency of the imidazolines oxymetazoline and xylometazoline at these α-adrenoceptor subtypes were examined in transfected HEK293 cells. The rank order of mRNA levels of α-adrenoceptor subtypes in human nasal mucosa was: α(2A) > α(1A) ≥ α(2B) > α(1D) ≥ α(2C) >> α(1B) . Oxymetazoline and xylometazoline exhibited in radioligand competition studies higher affinities than the catecholamines adrenaline and noradrenaline at most α-adrenoceptor subtypes. Compared to xylometazoline, oxymetazoline exhibited a significantly higher affinity at α(1A) - but a lower affinity at α(2B) -adrenoceptors. In functional studies in which adrenoceptor-mediated Ca(2+) signals were measured, both, oxymetazoline and xylometazoline behaved at α(2B) -adrenoceptors as full agonists but oxymetazoline was significantly more potent than xylometazoline. Furthermore, oxymetazoline was also a partial agonist at α(1A) -adrenoceptors; however, its potency was relatively low and it was much lower than its affinity. The higher potency at α(2B) -adrenoceptors, i.e. at receptors highly expressed at the mRNA level in human nasal mucosa, could eventually explain why in nasal decongestants oxymetazoline can be used in lower concentrations than xylometazoline.

PubMed Disclaimer

Cited by

Oxymetazoline Metered Dose Spray: Factors Affecting Delivery Volume.
Hakim M, Walia H, Rafiq M, Grannell T, Cartabuke RS, Tobias JD. Hakim M, et al. J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):247-51. doi: 10.5863/1551-6776-21.3.247. J Pediatr Pharmacol Ther. 2016. PMID: 27453703 Free PMC article.
Structural basis of α_1A-adrenergic receptor activation and recognition by an extracellular nanobody.
Toyoda Y, Zhu A, Kong F, Shan S, Zhao J, Wang N, Sun X, Zhang L, Yan C, Kobilka BK, Liu X. Toyoda Y, et al. Nat Commun. 2023 Jun 20;14(1):3655. doi: 10.1038/s41467-023-39310-x. Nat Commun. 2023. PMID: 37339967 Free PMC article.
Dexmedetomidine and fentanyl exhibit temperature dependent effects on human respiratory cilia.
Welchering N, Ochoa S, Tian X, Francis R, Zahid M, Muñoz R, Lo CW. Welchering N, et al. Front Pediatr. 2015 Feb 11;3:7. doi: 10.3389/fped.2015.00007. eCollection 2015. Front Pediatr. 2015. PMID: 25717467 Free PMC article.
Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies.
Price FW Jr, Hom M, Moshirfar M, Evans D, Liu H, Penzner J, Robinson MR, Lee S, Wirta DL. Price FW Jr, et al. Ophthalmol Sci. 2021 Oct 2;1(4):100065. doi: 10.1016/j.xops.2021.100065. eCollection 2021 Dec. Ophthalmol Sci. 2021. PMID: 36246939 Free PMC article.
A Novel "Activation Switch" Motif Common to All Aminergic Receptors.
Lee KH, Manning JJ, Javitch J, Shi L. Lee KH, et al. J Chem Inf Model. 2023 Aug 28;63(16):5001-5017. doi: 10.1021/acs.jcim.3c00732. Epub 2023 Aug 4. J Chem Inf Model. 2023. PMID: 37540602 Free PMC article. Review.

Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline - PubMed